Published in Proteome Sci on May 29, 2012
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development. Clin Transl Med (2014) 1.05
Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel. PLoS One (2012) 0.96
Functional phosphoproteomic mass spectrometry-based approaches. Clin Transl Med (2012) 0.83
Phosphoproteomics and lung cancer research. Int J Mol Sci (2012) 0.79
Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia. J Cell Mol Med (2014) 0.77
A proteomic approach to obesity and type 2 diabetes. J Cell Mol Med (2015) 0.76
Study of phosphorylation events for cancer diagnoses and treatment. Clin Transl Med (2015) 0.75
Molecules as documents of evolutionary history. J Theor Biol (1965) 12.52
Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol (2006) 10.14
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics (2005) 8.92
A semiempirical free energy force field with charge-based desolvation. J Comput Chem (2007) 8.40
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Current two-dimensional electrophoresis technology for proteomics. Proteomics (2004) 4.87
Decoding signalling networks by mass spectrometry-based proteomics. Nat Rev Mol Cell Biol (2010) 3.78
Multiplex protein assays based on real-time magnetic nanotag sensing. Proc Natl Acad Sci U S A (2008) 3.34
Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods (2010) 2.95
A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol (2011) 2.91
Next-generation high-density self-assembling functional protein arrays. Nat Methods (2008) 2.46
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat Biotechnol (2011) 2.44
Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol (2004) 2.42
The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem (2009) 2.23
Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. PLoS One (2010) 2.10
Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS One (2009) 2.04
Head-to-head comparison of serum fractionation techniques. J Proteome Res (2007) 1.98
Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures. Anal Chem (2004) 1.94
Proteomics: a new diagnostic frontier. Clin Chem (2006) 1.82
Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J Proteome Res (2010) 1.75
Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol (2007) 1.60
Strong FtsZ is with the force: mechanisms to constrict bacteria. Trends Microbiol (2010) 1.58
Pharmacological reactivation of mutant p53: from protein structure to the cancer patient. Oncogene (2010) 1.54
Proteomic analysis of organ-specific post-translational lysine-acetylation and -methylation in mice by use of anti-acetyllysine and -methyllysine mouse monoclonal antibodies. Proteomics (2005) 1.46
Role of clinical bioinformatics in the development of network-based Biomarkers. J Clin Bioinforma (2011) 1.38
Zonal uniformity in mechanical properties of the chondrocyte pericellular matrix: micropipette aspiration of canine chondrons isolated by cartilage homogenization. Ann Biomed Eng (2005) 1.19
Proteomics: new technologies and clinical applications. Eur J Cancer (2008) 1.19
Multiplexed microbead immunoassays by flow cytometry for molecular profiling: Basic concepts and proteomics applications. Crit Rev Biotechnol (2009) 1.18
Phage-display and correlated mutations identify an essential region of subdomain 1C involved in homodimerization of Escherichia coli FtsA. Proteins (2003) 1.17
Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? Clin Chem (2005) 1.16
Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight protein. ACS Nano (2010) 1.16
The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Target Oncol (2009) 1.10
Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays. J Immunol Methods (2009) 1.10
Systematic analysis of the IgG antibody immune response against varicella zoster virus (VZV) using a self-assembled protein microarray. Mol Biosyst (2010) 1.09
Profiling carbonylated proteins in human plasma. J Proteome Res (2010) 1.09
Recent advances in blood-related proteomics. Proteomics (2005) 1.09
The evolving role of mass spectrometry in cancer biomarker discovery. Cancer Biol Ther (2009) 1.09
Methods for samples preparation in proteomic research. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.08
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. Eur Respir J (2009) 1.08
Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations. J Proteome Res (2010) 1.07
A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation. J Biomed Biotechnol (2009) 1.05
Trends in sample preparation for classical and second generation proteomics. J Chromatogr A (2007) 1.05
3-D structure and dynamics of protein kinase B-new mechanism for the allosteric regulation of an AGC kinase. J Chem Biol (2009) 1.05
Clinical and technical phosphoproteomic research. Proteome Sci (2011) 1.04
In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol Cell Proteomics (2010) 1.03
Structural and functional model for ionic (K(+)/Na(+)) and pH dependence of GTPase activity and polymerization of FtsZ, the prokaryotic ortholog of tubulin. J Mol Biol (2009) 1.03
Bioinformatic-driven search for metabolic biomarkers in disease. J Clin Bioinforma (2011) 1.02
Solubilization of proteins for electrophoretic analyses. Electrophoresis (1996) 1.01
Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis. J Proteome Res (2009) 1.00
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker. Clin Colorectal Cancer (2009) 1.00
The modernisation of pathology and laboratory medicine in the UK: networking into the future. Clin Biochem Rev (2008) 0.99
Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase. J Proteome Res (2010) 0.94
Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma. J Proteome Res (2008) 0.92
The evolving discipline of molecular epidemiology of cancer. Carcinogenesis (2009) 0.92
In silico activation of Src tyrosine kinase reveals the molecular basis for intramolecular autophosphorylation. J Mol Graph Model (2004) 0.92
A glycomics approach to the discovery of potential cancer biomarkers. Methods Mol Biol (2010) 0.89
Molecular-targeted therapies: lessons from years of clinical development. Cancer Treat Rev (2007) 0.89
Microfluidic chips for mass spectrometry-based proteomics. J Mass Spectrom (2009) 0.88
Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc (2011) 0.87
Emerging nanoproteomics approaches for disease biomarker detection: a current perspective. J Proteomics (2011) 0.86
Proteomic analysis in cancer research: potential application in clinical use. Clin Transl Oncol (2006) 0.84
Relevant phosphoproteomic and mass spectrometry: approaches useful in clinical research. Clin Transl Med (2012) 0.83
Development of novel IVD assays: a manufacturer's perspective. Scand J Clin Lab Invest Suppl (2010) 0.82
Quantitative serum proteomics using dual stable isotope coding and nano LC-MS/MSMS. J Proteome Res (2009) 0.81
Discovering and validating unknown phospho-sites from p38 and HuR protein kinases in vitro by Phosphoproteomic and Bioinformatic tools. J Clin Bioinforma (2011) 0.81
Sample treatments prior to capillary electrophoresis-mass spectrometry. J Chromatogr A (2006) 0.80
Phosphorylation modulates the alpha-helical structure and polymerization of a peptide from the third tau microtubule-binding repeat. Biochim Biophys Acta (2004) 0.80
Streamlining biomarker discovery. Nat Biotechnol (2011) 0.79
Usage of troponin in the real world: a lesson for the introduction of biochemical assays. QJM (2005) 0.79
Recent advances in clinical proteomics using mass spectrometry. Bioanalysis (2010) 0.78
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell (2002) 8.38
p97: The cell's molecular purgatory? Mol Cell (2006) 2.23
Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. Genome Res (2004) 2.22
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. Pediatr Infect Dis J (2010) 1.66
Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology (2007) 1.48
Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation. Mol Cell Biol (2009) 1.47
[Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update]. Enferm Infecc Microbiol Clin (2011) 1.46
Uncoupling retro-translocation and degradation in the ER-associated degradation of a soluble protein. EMBO J (2004) 1.38
A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network. J Med Genet (2006) 1.30
Effects of an intrahospital exercise program intervention for children with leukemia. Med Sci Sports Exerc (2007) 1.19
Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. Blood (2011) 1.18
DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP. Mol Biol Cell (2003) 1.17
Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group. J Clin Oncol (2005) 1.15
KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors. Pediatr Blood Cancer (2009) 1.11
Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients. Mol Ther (2009) 1.07
Werner syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent fashion. J Struct Biol (2004) 1.07
GTPase-mediated regulation of the unfolded protein response in Caenorhabditis elegans is dependent on the AAA+ ATPase CDC-48. Mol Cell Biol (2008) 1.06
Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation. Eur J Haematol (2006) 1.05
High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol (2005) 1.01
Early-phase adaptations to intrahospital training in strength and functional mobility of children with leukemia. J Strength Cond Res (2007) 0.97
Identification of Caspase-6-mediated processing of the valosin containing protein (p97) in Alzheimer's disease: a novel link to dysfunction in ubiquitin proteasome system-mediated protein degradation. J Neurosci (2010) 0.97
Fatal hepatic failure secondary to acute herpes simplex virus infection. J Pediatr Hematol Oncol (2004) 0.94
Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact. J Med Genet (2011) 0.93
Physical activity during treatment in children with leukemia: a pilot study. Appl Physiol Nutr Metab (2006) 0.93
Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors. Cancer Gene Ther (2005) 0.91
Exercise during hematopoietic stem cell transplant hospitalization in children. Med Sci Sports Exerc (2010) 0.91
Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study. J Pediatr Hematol Oncol (2009) 0.89
Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation. Haematologica (2002) 0.87
Risks and methods for peripheral blood progenitor cell collection in small children. Transfus Apher Sci (2004) 0.86
Severe systemic autoimmune disease associated with Epstein-Barr virus infection. J Pediatr Hematol Oncol (2004) 0.85
Proteomics of nasal mucus in chronic rhinosinusitis. Am J Rhinol (2008) 0.85
Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation. Br J Haematol (2002) 0.85
High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol (2004) 0.84
Preliminary findings of a 4-month intrahospital exercise training intervention on IGFs and IGFBPs in children with leukemia. J Strength Cond Res (2010) 0.83
Functional phosphoproteomic mass spectrometry-based approaches. Clin Transl Med (2012) 0.83
Relevant phosphoproteomic and mass spectrometry: approaches useful in clinical research. Clin Transl Med (2012) 0.83
Priming of hematopoietic progenitor cells by plerixafor and filgrastim in children with previous failure of mobilization with chemotherapy and/or cytokine treatment. J Pediatr Hematol Oncol (2012) 0.83
Aleukemic congenital leukemia cutis. Pediatr Dermatol (2004) 0.82
Allogeneic cord blood transplantation in children with hematological malignancies: a long-term follow-up single-center study. Pediatr Hematol Oncol (2009) 0.82
Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination. Mediterr J Hematol Infect Dis (2012) 0.82
TOE1 interacts with p53 to modulate its transactivation potential. FEBS Lett (2009) 0.81
Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities. J Cell Mol Med (2014) 0.81
High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk ewing sarcoma patients: a long-term follow-up single-center study. Pediatr Hematol Oncol (2010) 0.81
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study. Neuro Oncol (2013) 0.81
Streamlining biomarker discovery. Nat Biotechnol (2011) 0.79
Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse. Am J Hematol (2013) 0.79
Chemotherapy-related secondary acute myeloid leukemia in patients diagnosed with osteosarcoma. J Pediatr Hematol Oncol (2004) 0.79
Mesenchymal stem cells are of recipient origin in pediatric transplantations using umbilical cord blood, peripheral blood, or bone marrow. J Pediatr Hematol Oncol (2007) 0.78
Rituximab in lymphomatoid granulomatosis. J Pediatr Hematol Oncol (2014) 0.78
Molecular systems biology at the crossroads: to know less about more, or to know more about less? Proteome Sci (2005) 0.78
Loss of heterozygosity of p16 correlates with minimal residual disease at the end of the induction therapy in non-high risk childhood B-cell precursor acute lymphoblastic leukemia. Leuk Res (2002) 0.78
Heparin based anticoagulation during peripheral blood stem cell collection may increase the CD34+ cell yield. Haematologica (2004) 0.78
Engraftment syndrome emerges as the main cause of transplant-related mortality in pediatric patients receiving autologous peripheral blood progenitor cell transplantation. J Pediatr Hematol Oncol (2004) 0.78
Risk score for pediatric intensive care unit admission in children undergoing hematopoietic stem cell transplantation and analysis of predictive factors for survival. J Pediatr Hematol Oncol (2005) 0.78
Peripheral blood progenitor cell collection adverse events for childhood allogeneic donors: variables related to the collection and safety profile. Br J Haematol (2008) 0.77
Flow cytometric assessment of hematopoietic cell subsets in cryopreserved preterm and term cord blood, influence of obstetrical parameters, and availability for transplantation. Am J Hematol (2006) 0.77
Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia. J Cell Mol Med (2014) 0.77
Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors. J Neurooncol (2009) 0.77
Reliability and validity of a new objective tool for low back pain functional assessment. Spine (Phila Pa 1976) (2011) 0.76
Defining "poor mobilizer" in pediatric patients who need an autologous peripheral blood progenitor cell transplantation. Cytotherapy (2013) 0.75
Publishing proteomic data. Proteome Sci (2006) 0.75
Study of phosphorylation events for cancer diagnoses and treatment. Clin Transl Med (2015) 0.75
Management of children with brain tumors in Paraguay. Neuro Oncol (2012) 0.75
A persistent epidural mass in a child with B-lineage ALL. Pediatr Blood Cancer (2010) 0.75
Hemiparesis in an Adolescent With Acute Lymphoblastic Leukemia: Everything Is Not Always What it Seems. J Pediatr Hematol Oncol (2016) 0.75
Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child. J Neurooncol (2007) 0.75
Extramedullary acute lymphoblastic leukaemia in childhood. Eur J Haematol (2007) 0.75
Dyspnea as the first manifestation of primary pancreatic lymphoma. Pediatr Blood Cancer (2008) 0.75
Peripheral blood progenitor cell collection in low-weight children. J Hematother Stem Cell Res (2002) 0.75
Cunninghamella bertholletiae infection in children: review and report of 2 cases with disseminated infection. J Pediatr Hematol Oncol (2014) 0.75
Early onset of acute immune-mediated lung injury in a child undergoing allogeneic peripheral blood transplantation. Am J Hematol (2002) 0.75
Very late isolated CNS relapse of acute myeloid leukemia. J Pediatr Hematol Oncol (2013) 0.75
Fatal Hepatic Failure Secondary to Acute Herpes Simplex Virus Infection. J Pediatr Hematol Oncol (2004) 0.75
[Frequent, acute episodes of normocytic anemia in a patient with AIDS]. Enferm Infecc Microbiol Clin (2002) 0.75
Immunomagnetic T Cell Depletion: an Analysis of Variables Affecting Final Cell Yield. Clin Lab (2016) 0.75
Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients. Br J Haematol (2007) 0.75
Pantoea agglomerans bacteremia in a child with acute lymphoblastic leukemia during induction therapy. J Pediatr Hematol Oncol (2015) 0.75
Early acute myeloblastic leukemia treatment for childhood myelodysplastic syndrome with t(3;5) (NPM/MLF1). J Pediatr Hematol Oncol (2007) 0.75
Building a National Pediatric Cancer Center and Network in Paraguay: Lessons for Addressing Challenges in a Low-income Country. J Pediatr Hematol Oncol (2015) 0.75
Clinical and economic evaluation of using granulocyte colony-stimulating factor after autologous peripheral blood progenitor cell transplantation in children. Haematologica (2002) 0.75
A role for the CXCR3/CXCL10 axis in Rasmussen encephalitis. Pediatr Neurol (2013) 0.75
Update on bacteraemia in oncology and hematology. Enferm Infecc Microbiol Clin (2011) 0.75